AEON Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Aeon Biopharma Inc (AEON) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available for investment. The company shows weak financial performance, no significant trading trends, and no positive catalysts. Additionally, technical indicators do not suggest a strong entry point, and there are no proprietary trading signals to support a buy decision.
The MACD is negative and expanding, indicating bearish momentum. RSI is at 34.352, which is neutral but leaning toward oversold territory. Moving averages are converging, showing no clear trend. The stock is trading below the pivot point of 1.193, with support at 1.02 and resistance at 1.366.
NULL identified. No recent news, no significant insider or hedge fund activity, and no congress trading data.
Weak financial performance with a YoY decline in net income (-26.46%) and EPS (-96.53%). The stock has shown a consistent price decline in the regular market (-5.50%) and pre-market (-0.92%).
In Q3 2025, revenue remained at 0 with no growth. Net income dropped to -$4,538,000, down 26.46% YoY. EPS fell significantly to -0.39, a 96.53% decline YoY. Gross margin remained at 0 with no growth.
No data available on analyst ratings or price target changes.
